Article metrics

other Versions

Download PDFPDF

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

 

Online download statistics by month:

Online download statistics by month: June 2020 to April 2021

AbstractFullPdf
Jun 202013112344
Jul 202019819054
Aug 202036235461
Sep 202018418227
Oct 202012212213
Nov 2020868522
Dec 2020635818
Jan 2021807624
Feb 2021797316
Mar 202113313128
Apr 202116162
Total14541410309